UK Regulator Approves Johnson & Johnson's Oral Psoriasis Treatment

The UK regulatory authority has approved a new oral treatment for plaque psoriasis developed by a Johnson & Johnson unit, marking a significant milestone for the company's pharmaceutical portfolio in the region. This treatment aims to offer a new therapeutic option for patients with the condition.